Feng Biao, vice chairman of Jiaying Pharmaceutical, was included in the list of dishonest executors and has submitted a resignation report

On the evening of December 8, Jiaying Pharmaceutical (002198) disclosed that Feng Biao, a non-independent director and vice chairman of the company's sixth board of directors, was included in the list of dishonest executors, and on December 8, the company received Feng Biao's resignation report in the mailbox.

Jiaying Pharmaceutical said that Feng Biao's inclusion in the list of dishonest executors this time was the implementation of the dispute between the plaintiff Orient Securities and the defendants Beijing Orient Junsheng Investment Management Co., Ltd., Feng Biao, Gao Zhonglin, Zhan Sufen and Xiang Ping over the pledged securities repurchase involving the shares of Hainan Coconut Island Group Co., Ltd.

Jiaying Pharmaceutical also said that on December 8, the company's mailbox received a resignation report from Feng Biao, who believed that the company had major defects in the corporate governance structure, and applied to the company's board of directors to resign as a non-independent director and vice chairman of the company's sixth board of directors, and the resignation report took effect from the date it was delivered to the board of directors. After resigning, Feng Biao will no longer hold any position in the company. As of the date of the announcement, Feng Biao was the actual controller of Shenzhen Tiger Hui Asset Management Co., Ltd., the company's largest shareholder.